Labquality EQAS by Aurevia
Mycobacterium tuberculosis, drug resistance
CLINICAL MICROBIOLOGY
Scheme information
Service
Labquality EQAS
Scheme
Mycobacterium tuberculosis, drug resistance
Service provider
Aurevia
Accreditation
ISO/EN 17043 (PT02/FINAS)
Status
Running
Target
Laboratories
Coverage
Analytical phase
Rounds
4
Distributions
Globally available
Coordinators
Jaana Paakkanen
Experts
Silja Mentula
Products
5230 /
Mycobacterium tuberculosis, drug resistance
Samples: 2 simulated samples, 1 mL
Type: Physical sample
Examinations: Mycobacterium tuberculosis nucleic acid detection, rifampicin susceptibility and isoniazid susceptibility
Additional information:
5231 /
Mycobacterium tuberculosis, drug resistance, nucleic acid detection, extra set of samples
Samples: 2 simulated samples, 1 mL
Type: Physical sample
Examinations:
Additional information: Only in connection with scheme 5230
Contact us
Jaana Paakkanen
EQA Coordinator
jaana.paakkanen@aurevia.com
+358 9 8566 8200